Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PLURI (PLUR)

  • Technical Exchange News
  • Sept. 12, 2025, 01:38 UTC
  • 20
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

OneMedNet Inc. (ONMDW)

  • Technical Exchange News
  • Sept. 12, 2025, 01:38 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

BioSig Technologies Inc. (BSGM)

  • Technical Exchange News
  • Sept. 12, 2025, 01:38 UTC
  • 21
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Sept. 12, 2025, 01:03 UTC
  • 18
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: DURECT Corporation - Common Stock. New value: DURECT Corporation - Common Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • Sept. 12, 2025, 01:03 UTC
  • 19
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Cyclacel Pharmaceuticals, Inc. - Common Stock. New value: Cyclacel Pharmaceuticals, Inc. - Common Stock.

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Sept. 12, 2025, 01:03 UTC
  • 18
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: DURECT Corporation - Common Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Sept. 12, 2025, 01:03 UTC
  • 20
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Sept. 12, 2025, 01:03 UTC
  • 18
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • Sept. 12, 2025, 01:03 UTC
  • 17
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • Sept. 12, 2025, 01:03 UTC
  • 22
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - Common Stock.

Comment Full text
  • Previous
  • 25
  • 26
  • 27
  • 28
  • 29
  • Next

Search

News categories

  • Technical Exchange News(10266)
  • Event(1436)
  • SEC News(174177)
  • FDA Approval(9605)
  • Company Report(721)
  • Business News(116935)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin